158 related articles for article (PubMed ID: 21773727)
1. Anti-proliferative effects of O-acyl-low-molecular-weight heparin derivatives on bovine pulmonary artery smooth muscle cells.
Garg HG; Mrabat H; Yu L; Hales CA; Li B; Moore CN; Zhang F; Linhardt RJ
Glycoconj J; 2011 Aug; 28(6):419-26. PubMed ID: 21773727
[TBL] [Abstract][Full Text] [Related]
2. Increase in the growth inhibition of bovine pulmonary artery smooth muscle cells by an O-hexanoyl low-molecular-weight heparin derivative.
Garg HG; Hales CA; Yu L; Butler M; Islam T; Xie J; Linhardt RJ
Carbohydr Res; 2006 Nov; 341(15):2607-12. PubMed ID: 16920092
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of bovine pulmonary artery smooth muscle cells following long-term heparin treatment.
Mrabat H; Garg HG; Hales CA
J Cell Physiol; 2009 Dec; 221(3):603-8. PubMed ID: 19653229
[TBL] [Abstract][Full Text] [Related]
4. Effect of carboxyl-reduced heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.
Garg HG; Mrabat H; Yu L; Freeman C; Li B; Zhang F; Linhardt RJ; Hales CA
Carbohydr Res; 2010 Jun; 345(9):1084-7. PubMed ID: 20399420
[TBL] [Abstract][Full Text] [Related]
5. Significance of the 2-O-sulfo group of L-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.
Garg HG; Mrabat H; Yu L; Freeman C; Li B; Zhang F; Linhardt RJ; Hales CA
Carbohydr Res; 2008 Sep; 343(14):2406-10. PubMed ID: 18656855
[TBL] [Abstract][Full Text] [Related]
6. Sulfation patterns in heparin and heparan sulfate: effects on the proliferation of bovine pulmonary artery smooth muscle cells.
Garg HG; Yu L; Hales CA; Toida T; Islam T; Linhardt RJ
Biochim Biophys Acta; 2003 Nov; 1639(3):225-31. PubMed ID: 14636954
[TBL] [Abstract][Full Text] [Related]
7. Influence of molecular weight, protein core and charge of native heparin fractions on pulmonary artery smooth muscle cell proliferation.
Joseph PA; Garg HG; Thompson BT; Liu X; Hales CA
Biochem Biophys Res Commun; 1997 Dec; 241(1):18-23. PubMed ID: 9405227
[TBL] [Abstract][Full Text] [Related]
8. Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site.
Islam T; Butler M; Sikkander SA; Toida T; Linhardt RJ
Carbohydr Res; 2002 Nov; 337(21-23):2239-43. PubMed ID: 12433488
[TBL] [Abstract][Full Text] [Related]
9. Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells.
Garg HG; Thompson BT; Hales CA
Am J Physiol Lung Cell Mol Physiol; 2000 Nov; 279(5):L779-89. PubMed ID: 11053011
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
[TBL] [Abstract][Full Text] [Related]
11. Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives.
Edens RE; al-Hakim A; Weiler JM; Rethwisch DG; Fareed J; Linhardt RJ
J Pharm Sci; 1992 Aug; 81(8):823-7. PubMed ID: 1328601
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight (LMW) heparin inhibits injury-induced femoral artery remodeling in mouse via upregulating CD44 expression.
Zhao G; Shaik RS; Zhao H; Beagle J; Kuo S; Hales CA
J Vasc Surg; 2011 May; 53(5):1359-1367.e3. PubMed ID: 21276692
[TBL] [Abstract][Full Text] [Related]
13. Heparin oligosaccharide sequence and size essential for inhibition of pulmonary artery smooth muscle cell proliferation.
Garg HG; Cindhuchao N; Quinn DA; Hales CA; Thanawiroon C; Capila I; Linhardt RJ
Carbohydr Res; 2002 Nov; 337(21-23):2359-64. PubMed ID: 12433502
[TBL] [Abstract][Full Text] [Related]
14. Enhanced effects of low molecular weight heparin intercalated with layered double hydroxide nanoparticles on rat vascular smooth muscle cells.
Gu Z; Rolfe BE; Xu ZP; Thomas AC; Campbell JH; Lu GQ
Biomaterials; 2010 Jul; 31(20):5455-62. PubMed ID: 20409578
[TBL] [Abstract][Full Text] [Related]
15. Sodium spirulan as a potent inhibitor of arterial smooth muscle cell proliferation in vitro.
Kaji T; Okabe M; Shimada S; Yamamoto C; Fujiwara Y; Lee JB; Hayashi T
Life Sci; 2004 Mar; 74(19):2431-9. PubMed ID: 14998720
[TBL] [Abstract][Full Text] [Related]
16. Effect of fully sulfated glycosaminoglycans on pulmonary artery smooth muscle cell proliferation.
Garg HG; Joseph PA; Thompson BT; Hales CA; Toida T; Imanari T; Capila I; Linhardt RJ
Arch Biochem Biophys; 1999 Nov; 371(2):228-33. PubMed ID: 10545209
[TBL] [Abstract][Full Text] [Related]
17. Effect of m-calpain in PKCalpha-mediated proliferation of pulmonary artery smooth muscle cells by low dose of ouabain.
Shaikh S; Sarkar J; Pramanik A; Karmakar K; Chakraborti S
Indian J Biochem Biophys; 2013 Oct; 50(5):419-27. PubMed ID: 24772963
[TBL] [Abstract][Full Text] [Related]
18. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
19. Heparin reduces overcirculation-induced pulmonary artery remodeling through p38 MAPK in piglet.
Zhao G; Seng J; Beagle J; Syrkina O; Hales CA
Ann Thorac Surg; 2015 May; 99(5):1677-84. PubMed ID: 25818573
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative role of 3-O-sulfate glucosamine in heparin on cultured pulmonary artery smooth muscle cells.
Garg HG; Joseph PA; Yoshida K; Thompson BT; Hales CA
Biochem Biophys Res Commun; 1996 Jul; 224(2):468-73. PubMed ID: 8702412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
